HBV prophylaxis: cost/benefit analysis following liver transplantation for HBV-positive liver cirrhosis.
Golling
M
M
Department of General Surgery and Medicine, University of Heidelberg, Germany.
Arnold
J C
JC
Rudek
B
B
Mehrabi
A
A
Kraus
T
T
Herfarth
C
C
Klar
E
E
D000328:Adult; D003362:Cost-Benefit Analysis; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D005858:Germany; D006509:Hepatitis B / Q000191:economics / Q000517:prevention & control* / Q000601:surgery*; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000302:isolation & purification; D006801:Humans; D007116:Immunization, Passive / Q000191:economics*; D007136:Immunoglobulins / Q000191:economics*; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery*; D016031:Liver Transplantation / Q000191:economics; D008297:Male; D012008:Recurrence; D012189:Retrospective Studies
D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D007136:Immunoglobulins; C045213:hepatitis B hyperimmune globulin